These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 11935040)

  • 1. Increased circulating immune complexes in acute stroke: the triggering role of Chlamydia pneumoniae and cytomegalovirus.
    Tarnacka B; Gromadzka G; Członkowska A
    Stroke; 2002 Apr; 33(4):936-40. PubMed ID: 11935040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serological markers of Chlamydia pneumoniae, cytomegalovirus and Helicobacter pylori infection in diabetic and non-diabetic patients with unstable angina pectoris.
    Altannavch Ts; Roubalová K; Broz J; Hrubá D; Andĕl M
    Cent Eur J Public Health; 2003 Jun; 11(2):102-6. PubMed ID: 12884557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chlamydia pneumoniae but not cytomegalovirus antibodies are associated with future risk of stroke and cardiovascular disease: a prospective study in middle-aged to elderly men with treated hypertension.
    Fagerberg B; Gnarpe J; Gnarpe H; Agewall S; Wikstrand J
    Stroke; 1999 Feb; 30(2):299-305. PubMed ID: 9933263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Infections, immunity, and atherosclerosis: associations of antibodies to Chlamydia pneumoniae, Helicobacter pylori, and cytomegalovirus with immune reactions to heat-shock protein 60 and carotid or femoral atherosclerosis.
    Mayr M; Kiechl S; Willeit J; Wick G; Xu Q
    Circulation; 2000 Aug; 102(8):833-9. PubMed ID: 10952949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chlamydia pneumoniae-specific circulating immune complexes in patients with chronic coronary heart disease.
    Linnanmäki E; Leinonen M; Mattila K; Nieminen MS; Valtonen V; Saikku P
    Circulation; 1993 Apr; 87(4):1130-4. PubMed ID: 8484830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic Chlamydia pneumoniae infection as a risk factor for coronary heart disease in the Helsinki Heart Study.
    Saikku P; Leinonen M; Tenkanen L; Linnanmäki E; Ekman MR; Manninen V; Mänttäri M; Frick MH; Huttunen JK
    Ann Intern Med; 1992 Feb; 116(4):273-8. PubMed ID: 1733381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chlamydia pneumoniae and cytomegalovirus seropositivity, inflammatory markers, and the risk of myocardial infarction at a young age.
    Gattone M; Iacoviello L; Colombo M; Castelnuovo AD; Soffiantino F; Gramoni A; Picco D; Benedetta M; Giannuzzi P
    Am Heart J; 2001 Oct; 142(4):633-40. PubMed ID: 11579353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating immune complexes containing chlamydial lipopolysaccharide in acute myocardial infarction.
    Leinonen M; Linnanmäki E; Mattila K; Nieminen MS; Valtonen V; Leirisalo-Repo M; Saikku P
    Microb Pathog; 1990 Jul; 9(1):67-73. PubMed ID: 2077346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Baseline IgG antibody titers to Chlamydia pneumoniae, Helicobacter pylori, herpes simplex virus, and cytomegalovirus and the risk for cardiovascular disease in women.
    Ridker PM; Hennekens CH; Buring JE; Kundsin R; Shih J
    Ann Intern Med; 1999 Oct; 131(8):573-7. PubMed ID: 10523217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective study of Chlamydia pneumoniae IgG and IgA seropositivity and risk of incident ischemic stroke.
    Tanne D; Haim M; Boyko V; Goldbourt U; Reshef T; Adler Y; Brunner D; Mekori YA; Behar S
    Cerebrovasc Dis; 2003; 16(2):166-70. PubMed ID: 12792175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chlamydia pneumoniae, herpes simplex virus type 1, and cytomegalovirus and incident myocardial infarction and coronary heart disease death in older adults : the Cardiovascular Health Study.
    Siscovick DS; Schwartz SM; Corey L; Grayston JT; Ashley R; Wang SP; Psaty BM; Tracy RP; Kuller LH; Kronmal RA
    Circulation; 2000 Nov; 102(19):2335-40. PubMed ID: 11067785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of Chlamydia pneumoniae, helicobacter pylori and cytomegalovirus in coronary artery disease.
    Al-Ghamdi A; Jiman-Fatani AA; El-Banna H
    Pak J Pharm Sci; 2011 Apr; 24(2):95-101. PubMed ID: 21454155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of evidence for a pathogenic role of Chlamydia pneumoniae and cytomegalovirus infection in coronary atheroma formation.
    Daus H; Ozbek C; Saage D; Scheller B; Schieffer H; Pfreundschuh M; Gause A
    Cardiology; 1998 Oct; 90(2):83-8. PubMed ID: 9778543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chlamydia pneumoniae antibodies in various subtypes of ischemic stroke in Indian patients.
    Bandaru VC; Laxmi V; Neeraja M; Alladi S; Meena AK; Borgohain R; Keerthi AS; Kaul S
    J Neurol Sci; 2008 Sep; 272(1-2):115-22. PubMed ID: 18571201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequency of coexistence of cytomegalovirus and Chlamydia pneumoniae in atherosclerotic plaques.
    Qavi HB; Melnick JL; Adam E; Debakey ME
    Cent Eur J Public Health; 2000 May; 8(2):71-3. PubMed ID: 10857040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Serological markers of chronic Chlamydia pneumoniae and cytomegalovirus (CMV) infection in patients with peripheral occlusive artery disease--an initial report].
    Rabczyński M; Jakobsche U; Adamiec R
    Przegl Lek; 2007; 64(6):416-8. PubMed ID: 18159850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic infections and genetic factors in the development of ischemic stroke.
    Kis Z; Sas K; Gyulai Z; Treso B; Petrovay F; Kapusinszky B; Csire M; Endresz V; Burian K; Mandi Y; Vecsei L; Gonczol E
    New Microbiol; 2007 Jul; 30(3):213-20. PubMed ID: 17802898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of chlamydial infection with cerebrovascular disease.
    Wimmer ML; Sandmann-Strupp R; Saikku P; Haberl RL
    Stroke; 1996 Dec; 27(12):2207-10. PubMed ID: 8969782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Higher incidence of persistent chronic infection of Chlamydia pneumoniae among coronary artery disease patients in India is a cause of concern.
    Jha HC; Vardhan H; Gupta R; Varma R; Prasad J; Mittal A
    BMC Infect Dis; 2007 May; 7():48. PubMed ID: 17537253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The proatherogenic properties of lipoprotein(a) may be enhanced through the formation of circulating immune complexes containing Chlamydia pneumoniae-specific IgG antibodies.
    Glader CA; Boman J; Saikku P; Stenlund H; Weinehall L; Hallmanns G; Dahlén GH
    Eur Heart J; 2000 Apr; 21(8):639-46. PubMed ID: 10731401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.